abstract |
<p> The present disclosure relates to sulfonylurea compounds and related compounds useful in the treatment of a disorder sensitive to the modulation of cytokines such as IL-1β and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or components related to the inflammatory process </p> |